International Private Wealth Advisors LLC trimmed its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 10.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,656 shares of the company’s stock after selling 183 shares during the period. International Private Wealth Advisors LLC’s holdings in Clorox were worth $270,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Clorox by 0.3% in the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after acquiring an additional 48,632 shares during the period. Nuance Investments LLC boosted its stake in Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares during the period. Van ECK Associates Corp increased its position in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Clorox by 14.4% in the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after acquiring an additional 120,716 shares during the period. Finally, Acadian Asset Management LLC grew its stake in shares of Clorox by 26.5% in the first quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock valued at $135,099,000 after acquiring an additional 184,847 shares in the last quarter. 78.53% of the stock is owned by institutional investors.
Clorox Trading Down 0.1 %
Shares of NYSE CLX traded down $0.17 during trading on Thursday, reaching $165.19. The company had a trading volume of 73,462 shares, compared to its average volume of 1,238,664. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $169.09. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The stock has a market cap of $20.45 billion, a P/E ratio of 57.62, a PEG ratio of 3.04 and a beta of 0.41. The company’s fifty day moving average price is $162.38 and its 200-day moving average price is $147.21.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were given a dividend of $1.22 per share. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.95%. Clorox’s payout ratio is 170.04%.
Insider Buying and Selling
In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
CLX has been the subject of a number of analyst reports. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. JPMorgan Chase & Co. raised their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Citigroup upped their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, DA Davidson raised their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $155.00.
View Our Latest Stock Report on CLX
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Industrial Products Stocks Investing
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Stock Sentiment Analysis: How it Works
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.